Digital Pathology Market Is Poised to Reach an Estimated $437 Million by 2018 - New Research Report by MarketsandMarkets

Share Article

The demand for digital pathology is growing and is expected to continue to rise in the coming years as well. http://www.marketsandmarkets.com/Market-Reports/digital-pathology-market-844.html

MarketsandMarkets

MarketsandMarkets

Major Players are 3DHistech (Hungary), Leica Biosystems (Germany), Ventana Medical Systems (U.S.), Hamamatsu Photonics K.K. (Japan)

The global digital pathology market is witnessing a healthy growth and will continue to do so over the next five years. The factors contributing to this growth are the ease of consultation, shortage of pathologists in many regions of the world, and rising opportunities in the emerging nations. The Asian region is projected to have the highest growth rate, with growth hinged at China and India.

Full Report @ http://www.marketsandmarkets.com/Market-Reports/digital-pathology-market-844.html

Based on the revenues gained from digital pathology products and services, the overall digital pathology market is dominated by four major players contributing to approximately 76% of the digital pathology market. These players include Leica Biosystems (Germany), Ventana Medical Systems (U.S.), Hamamatsu (Japan), and 3DHistech (Hungary).

Leica Biosystems accounted for the largest share of this market in 2013. In October 2012, the company acquired Aperio Technologies. This acquisition enabled Leica to rise to the top of the ladder in the digital pathology market. The company engages in partnerships to achieve synergies. In January 2013, the company partnered with eyesFinder (U.S.), a leading developer of visual search technology, to create powerful decision support tools for pathologists. Furthermore, the worldwide network of the company is an important asset, as it has its presence in over 100 countries.

Get Report Inquiry @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=844

Ventana Medical Systems is another leading player in the digital pathology market. The company has been very active and has had many developments in the digital pathology segment. The company has received a number of 510 (k) clearances from the FDA. For instance, the company received 510 (k) clearances from the FDA for its Estrogen Receptor (ER) image analysis software. The company has entered into agreements to achieve synergies. For instance, in September 2013, Ventana signed an agreement with EMC Corporation to offer highly scalable and flexible solutions to store and archive medical images for anatomical pathology laboratories, as a part of the Ventana digital pathology solution.

In the Asian region, China is the leader of the digital pathology market. The companies in this market adopt the collaboration strategy to cater to the market in China. Western players collaborate with the local Chinese players to develop digital pathology solutions for the Chinese customers. For instance, in August 2013, MEDITE Inc., a subsidiary of Germany-based MEDITE Group, entered into a strategic alliance agreement with China-based UNIC Technologies. This agreement aimed to develop a complete digital pathology solution for the market in China. Furthermore, the ministry has encouraged hospitals in China to adopt digital pathology for cancer diagnosis. These developments are likely to boost the adoption for digital pathology in the country.

For PDF Manual @ http://www.marketsandmarkets.com/pdfdownload.asp?id=844

The North American market, comprising of U.S. and Canada, witnesses favorable reimbursement scenario and adoption of digital pathology systems. The shortage of pathologists, conferences, and favorable funding in some regions contributes to the growth of the European market. The market in the RoW is expected to witness a relative growth as well. This growth can be attributed to the use of digital pathology to aid in the quality and timely diagnosis of the patients in these regions.

The other players in this market include Mikroscan Technologies (U.S.), Definiens AG (Germany), Visiopharm (Denmark), Apollo PACS (U.S.), Kanteron Systems (Spain), Huron Technologies International Inc. (Canada), and Indica Labs (U.S.).

About MarketsandMarkets

MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
e-mail: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog@ http://mnmblog.org/market-research/healthcare/healthcareit

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Mr. Rohan
@marketsmarkets
since: 04/2009
Follow >
Market Research Report
since: 12/2010
Like >
Follow us on